Active ingredient: Fenofibric acid (as choline fenofibrate) 45 mg, 135 mg; delayed-release caps. Indications: Adjunct to diet: In combination with a statin, to reduce triglycerides (TG) and increase ...

March 25, 2011 (Pomona, California) — The use of fibrates in the US has increased steadily over the past 10 years and remained consistent in Canada, with the market share dominated by brand-name ...

Background: The incidence of hospitalized rhabdomyolysis is not well characterized among patients taking statin-fibrate combination therapies. OBJECTIVE: To estimate and compare the rates of ...

Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Fibrate Drugs Market by Drug Type, by Product Type, by Distribution Channel, and By Region" report has been added to ResearchAndMarkets.com's ...

Fenofibric Acid (Fibrate (200 mg)) is used to reduce the cholesterol in patients with obesity problem. It is a HMG-CoA reductase inhibitor (statin). It slows the production of cholesterol in the body.

Use of combination of statin with niacin or fenofibrate for the treatment of high cholesterol levels is no longer approved by the FDA. The FDA is withdrawing approvals on the use of combination of ...

Please provide your email address to receive an email when new articles are posted on . Patients who underwent fibrate therapy had a reduction in major CV and major coronary events, indicated study ...

APAC sees fibrates growth amidst urbanisation and healthcare spending. The fibrate drugs market is projected to reach a value of $1.8 b by 2034, with a compound annual growth rate of 2.12%, driven by ...

Fibrate use was associated with new onset CKD, but a lower risk for kidney failure. Fibrate therapy may lower the risks of mortality and progression to end-stage kidney disease (ESKD), despite raising ...

In a real-world Japanese study, recent fibrate use was associated with decreased odds of MACE among patients with CKD. Recent fibrate use is associated with reduced risks for major adverse ...

Older patients taking a common cholesterol medication should be cautious of the impact on their kidney health. In a new study by Dr. Amit Garg, Scientist at the Lawson Health Research Institute and ...